The present work, as a part of Prof. Iida's study on the sterilization by forming corpus luteum artificially, has been done to estimate the action of trophoblast hormone (T.B.H.) in relation to its luteinizing and luteotrophic effect.
In Part I of this report, the author examined critically the procedures of the quantitative determination of pregnanediol (PG) in urine. In his own work the author adopted with some modification the chromatographic methos of Watteville for extraction and purification of PG in urine and the sulphuric acid method of Guterman with spectrophotometry for its microdetermination. The sulphuric acid method is said to be the most accurate for microdetermination of PG, but it is not the characteristic reaction for PG alone, so the best attention was payed to extraction of PG from urine and its purification. Thus the author succeeded in isolating two samples of crystal with sublimating property from the urine of a pregnant woman. One of them was ketonic (pregnanedion) and the other non-ketonic (PG). Melting points and the result of the organic microanalysis were satisfactorily coincident with the theoretical values for each of them. Making use of this crystal in the sulphuric acid method of Guterman, the relation between the spectral absorption at 420mμ and the quantity (mg) of PG, i.e. the standard curve for the spectrophotometric microdetermination of PG, was decided by means of Beckman's spectrophotometer (type DU). The recovering test and some other tests confirmed the accuracy and the reliability of the method above-described for microdetermination of PG inurine.The author believes that this method may beused for clinical purposes.
In Part II of this report, the author tried to ascertain how the amount of PG in urine varies with the menstruation, the conception and related disorders or diseases. He also tried to elucidate the relation of PG in urine to T.B.H. administration, hypophyseal and suprarenal functions. The results were summarized as follows.
1) In the normal menstrual cycle, PG appeared in urine only at the luteal phase and its apPearance was less marked in the disorderly menstrual cycle. The time of ovulation may be more easily inferable by the appearance of PG in urine than by other methods now in use. When the periods were changed artificially by administration of T.B.H,, PG appeared a little earlier, if administered at the early estrogenic phase, but the T.B.H. administration at the luteal phase caused the elongation of the luteal phase, accompanied by a significant increase in PG excretion.
2) PG in urine refiected truly the ovarian function, particularly the corpus luteum activity, also in the irregular menstrual cycle. The unovulatory cycle were ascertained by PG determination in urine better than by endometrial examination or by B.B.T. test. It was also assured that T.B.H. administration served better in the cure of the irregular menstrual cyle or of the functional sterility than any other hormone therapy, from the view-point of the PG increase in urine.
3) In the earlier stages of the normal conception PG in urine did not show any marked increase as compared with that in the luteal phase, but after the 16th week it remarkably increased and reached its maximum at the 32nd week, which continued till parturition. After parturition PG in urine suddenly decreased and disappeared 98 hours after delivery.
4) The amount of PG in urine was remarkably less in the toxemia of pregnancy as compared with that in the normal conception. This fact was coincident with the results of other clinical examinatlons.Thus it may be presumable that the toxemia of pregnancy is caused by the disorderly renewal of hormones, so the determination of PG in urine may serve as a factor in judging the prognosis of thetoxemla.
5) By administration of T.B.H. for protection from the threatened abortion the amount of PG in urine increased, accompanied by the amelioration of symptoms.
抄録全体を表示